| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/07/2006 | EP1663299A2 Methods for preventing neurological events |
| 06/07/2006 | EP1663298A2 Use of proline specific endoproteases to hydrolyse peptides and proteins |
| 06/07/2006 | EP1663267A1 Oral compositions for the treatment of cellulite |
| 06/07/2006 | EP1663263A1 Use of adipose tissue cells for initiating the formation of a functional vascular network |
| 06/07/2006 | EP1663243A1 Pharmaceutical formulation comprising a pyrimidine-a-one derivative coated with an enteric polymer |
| 06/07/2006 | EP1663215A1 Novel medical use of selective cb1- receptor antagonists |
| 06/07/2006 | EP1663206A1 Nonsedating a-2 agonist 1-(2,3-dimethyl-phenyl)-ethyl-1,3-dihydro-imidazole-2-thione |
| 06/07/2006 | EP1663202A1 Substituted indoles as inhibitors of poly (adp-ribose) polymerase (parp) |
| 06/07/2006 | EP1663197A1 The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma |
| 06/07/2006 | EP1663192A1 Erg channel openers for the treatment of cardiac arrhythmias |
| 06/07/2006 | EP1494999B1 Occlusive composition comprising a poly(2-cyanoacrylate) monomer |
| 06/07/2006 | EP1492789B1 Tropane derivatives as ccr5 modulators |
| 06/07/2006 | EP1425029A4 Peptidomimetics of biologically active metallopeptides |
| 06/07/2006 | EP1409673B1 Human leucine-rich repeat containing protein, expressed predominantely in small intestine, hlrrsi1 |
| 06/07/2006 | EP1406878B1 4-(benzylidene-amino)-3-(methylsulfanyl)-4h-(1, 2, 4) triazin-5-one derivatives having a pde-iv inhibiting and tnf-antagonistic effect for the treatment of cardiac diseases and allergies |
| 06/07/2006 | EP1406614B1 Carvedilol polymorph |
| 06/07/2006 | EP1368355B1 Substituted pyrazolopyrimidines and thiazolopyrimidines |
| 06/07/2006 | EP1364023B1 Gene highly expressed in cartilage tissues |
| 06/07/2006 | EP1311478B1 Novel (thio)urea compounds and the pharmaceutical compositions containing the same |
| 06/07/2006 | EP1285654B1 Autonomic system controlling agents and health drinks and foods |
| 06/07/2006 | EP1259489B1 Aryl fused azapolycyclic compounds |
| 06/07/2006 | EP1254234B1 Haemophilus influenza outer membrane protein and use thereof in vaccination |
| 06/07/2006 | EP1171594B1 Vascular endothelial cell growth factor variants and uses thereof |
| 06/07/2006 | CN1784420A Method for the production of an N-terminally modified chemotactic factor |
| 06/07/2006 | CN1784415A Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 06/07/2006 | CN1784395A Piperazine-alkyl-ureido derivatives |
| 06/07/2006 | CN1784394A Novel piperidine derivatives |
| 06/07/2006 | CN1784235A Fortifier |
| 06/07/2006 | CN1784232A Therapeutic agents comprising an anti-angiogenic agent in combination with an src-inhibitor and their therapeutic use |
| 06/07/2006 | CN1784225A Angiotensin II receptor blockers for preventing the development or progression of microvascular disease due to diabetes |
| 06/07/2006 | CN1781920A Polycyclic guanine phosphodiesterase v inhibitor |
| 06/07/2006 | CN1781910A Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use |
| 06/07/2006 | CN1781554A Compound medicine for predicting ACEI pressure reducing medicine effect |
| 06/07/2006 | CN1781537A Shengmai injection and its preparing method |
| 06/07/2006 | CN1781531A Dragon's blood oil agent, soft capsule containing said oil agent and its preparing method |
| 06/07/2006 | CN1781504A Compound injection composed of borneol and wilsonii extract and its preparing method |
| 06/07/2006 | CN1781503A Ilex pubescens extract for treating angitis and its preparation |
| 06/07/2006 | CN1781496A Physiological water for promoting the secretion of saliva or body liquid |
| 06/07/2006 | CN1781490A Compound injection composed of borneol and erigeron breviscapus and its preparing method |
| 06/07/2006 | CN1781484A Compound nicotinic acid slow releasing capsule and its preparing method |
| 06/07/2006 | CN1258594C Long-noded pit viper poison dissolving fiber protein No.2 gene and use thereof |
| 06/07/2006 | CN1258563C Highly-neutralized ethylene copolymers and their use in golf balls |
| 06/07/2006 | CN1258377C Bamboo extract and its preparation method and application |
| 06/07/2006 | CN1258371C Compositions comprising organic extracts of Geum Japonicum thunb var. and the use thereof |
| 06/07/2006 | CN1258365C Pharmaceutical composition for treating cardiovascular and its preparing process |
| 06/07/2006 | CN1258363C Nimodipine adhesive sheet |
| 06/06/2006 | US7057076 which have improved receptor binding affinity via substituted alkyl side chains at the c-3 position; may contain terpene funtionality combined with resorcinol moieties; for treatment of nervous system disorders and cardiovascular disorders |
| 06/06/2006 | US7057036 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action |
| 06/06/2006 | US7057022 Antibodies which specifically bind to TNF-R |
| 06/06/2006 | US7056949 Liver disorders, dietetics; weight ratio of glycerides to diglycerides |
| 06/06/2006 | US7056944 Pyrazole compositions useful as inhibitors of erk |
| 06/06/2006 | US7056942 Carvedilol |
| 06/06/2006 | US7056938 Method for scavenging radicals with urocanic acid, derivatives and analogues |
| 06/06/2006 | US7056933 For therapy of arthritis, fever, common cold, dysmenorrhea, menstrual cramps, inflammatory bowel disease, Crohn's disease, emphysema, acute respiratory distress syndrome, asthma, bronchitis, chronic obstructive pulmonary disease, etc. |
| 06/06/2006 | US7056931 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods |
| 06/06/2006 | US7056926 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, particularly those diseases related to thrombosis |
| 06/06/2006 | US7056924 Substituted heterocyclic compounds |
| 06/06/2006 | US7056923 Anticoagulants |
| 06/06/2006 | US7056922 Acylamino cyclopropane derivatives |
| 06/06/2006 | US7056921 Substituted chroman derivatives |
| 06/06/2006 | US7056915 Compounds useful as reversible inhibitors of cysteine proteases |
| 06/06/2006 | US7056914 Benzoxazinone-derived compounds, their preparation and use as medicaments |
| 06/06/2006 | US7056910 1,4,5.6-tetrahydroimidazo[4,5-d]diazepine derivatives or salts thereof |
| 06/06/2006 | US7056909 5,5-Difluoro-3(S)-(pyrimidin-5-yl)-9-(5,6,7,8-tetrahydro-(1, 8)-naphthyridin-2-yl)-nonanoic acid; inhibition of bone resorption, restenosis, angiogenesis, retinopathy, macular degeneration, arthritis, metastatic tumor growth, etc. |
| 06/06/2006 | US7056904 Therapy for bone disorders; osteoporosis; vitamin deficiency |
| 06/06/2006 | US7056903 Administering a therapeutical carbamate derivative to a patient as prostaglandin IP (12 or PGI2) antagonists |
| 06/06/2006 | US7056902 4-dedimethylamino tetracycline compounds |
| 06/06/2006 | US7056887 Treatment of acute coronary syndrome with GLP-1 |
| 06/06/2006 | US7056885 Fibroblast growth factor and nucleic acids encoding same |
| 06/06/2006 | US7056712 Administering to the individual therapeutically effective amount of human acid alpha-glucosidase at regular interval for therapy of glycogen storage disease type II |
| 06/06/2006 | US7056662 Reducing the level of circulating free fatty acids by administering a compound that inhibits mal1, especially inhibiting transcription or translation of mal1 |
| 06/06/2006 | US7056525 Use thereof in human and animal foods, cosmetics and pharmaceuticals; soft gelatin capsules |
| 06/06/2006 | US7056514 Partial peptide mimetics and methods |
| 06/06/2006 | US7056509 Monoclonal antibodies used as antagonists vascular endothelial growth factors (VEGF); angiogenesis inhibitors; antitumor agents |
| 06/06/2006 | CA2327723C Bicyclic hydroxamic acid derivatives |
| 06/06/2006 | CA2053288C Expression of human apolipoproteins ai and ai-milano in yeast |
| 06/01/2006 | WO2006058303A2 Modulators of muscarinic receptors |
| 06/01/2006 | WO2006058199A1 Methods of modulating high-density lipoprotein cholesterol levels and pharmaceutical formulations for the same |
| 06/01/2006 | WO2006057972A1 Process for preparing novel crystalline forms of (2s)-1-[[(7r)-7-(3,4-dichlorophenyl)-4,7-dihydro-5-methylpyrazolo[1,5]pyrimidine-6-yl]carbonyl]-2-(4-fluorophenyl) pyrrolidine, novel stable forms produced therein and formulations |
| 06/01/2006 | WO2006057460A1 Nitrogen-containing fused ring compound and use thereof |
| 06/01/2006 | WO2006057397A1 (s)-(-)-1-(4-fluoroisoquinolin-5-yl)sulfonyl-2-methyl-1,4homopiperazine hydrochloride dihydrate |
| 06/01/2006 | WO2006057375A1 Medicinal preparation for external use |
| 06/01/2006 | WO2006057278A1 Remedy for heart disease using map kinase tnni3k |
| 06/01/2006 | WO2006057270A1 Nitrogeneous tricyclic compound |
| 06/01/2006 | WO2006057209A1 Pharmaceutical composition having action of lowering blood free fatty acid |
| 06/01/2006 | WO2006057152A1 Therapeutic agent for diabetes comprising protease-inhibiting compound |
| 06/01/2006 | WO2006056038A1 Pyridoxal-5-phosphate and stent for the treatment and prevention of atherosclerosis and restenosis |
| 06/01/2006 | WO2006031467A9 Isolated lineage negative hematopoietic stem cells and methods of treatment therewith |
| 06/01/2006 | WO2006014493A3 Mechanically activated channel blocker |
| 06/01/2006 | WO2005123051A3 Resorcinol derivatives for lowering blood pressure |
| 06/01/2006 | WO2005107752A3 Use of opioid receptor antagonist compounds for the prevention and/or treatment of diseases associated with the target calcineurin |
| 06/01/2006 | WO2004004656A3 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs |
| 06/01/2006 | WO2003025542A3 Immune response associated proteins |
| 06/01/2006 | US20060117414 Fad4, Fad5, Fad5-2, and Fad6, novel fatty acid desaturase family members and uses thereof |
| 06/01/2006 | US20060116518 Novel phenanthridines |
| 06/01/2006 | US20060116516 2-[[4-[[[4-(Aminosulfonyl)phenyl]methyl]amino]pyrido[2,3-d]pyrimidin-2-yl]amino]-4-methyl-5-thiazolecarboxylic acid, ethyl ester; 4-Methyl-2-[[4-[[[4-(methylsulfonyl)phenyl]methyl]amino]pyrido[2,3-d]pyrimidin-2-yl]amino]-5-thiazolecarboxylic acid, ethyl ester; Antiinflammatory agents; rheumatic diseases |
| 06/01/2006 | US20060116510 Isoflavone concentrates, as well as methods for their production |
| 06/01/2006 | US20060116403 Therapeutic target and uses thereof |
| 06/01/2006 | US20060116388 CXCR3 antagonists |
| 06/01/2006 | US20060116379 Compounds exhibiting type X sPLA2 inhibiting effect |